Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinoma

por Serzan, Michael T., Atkins, Michael B.
Publicado 2021

PD-1 as a potential target in cancer therapy

por McDermott, David F, Atkins, Michael B
Publicado 2013

Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma

por Rini, Brian I, Brugarolas, James, Atkins, Michael B
Publicado 2023

Advances in immunotherapy for melanoma

por Redman, Jason M., Gibney, Geoffrey T., Atkins, Michael B.
Publicado 2016

Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy

por Serzan, Michael T, Kumar, Princy N, Atkins, Michael B
Publicado 2020

Management of metastatic renal cell carcinoma in patients with poor prognosis

por Bullock, Andrea, McDermott, David F, Atkins, Michael B
Publicado 2010

What’s new in melanoma? Combination!

por Ascierto, Paolo A, Marincola, Francesco M, Atkins, Michael B
Publicado 2015

Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?

por Jonasch, Eric, Atkins, Michael B., Chowdhury, Simon, Mainwaring, Paul
Publicado 2022

A case of checkpoint inhibitor-induced celiac disease

por Alsaadi, Dana, Shah, Neil J., Charabaty, Aline, Atkins, Michael B.
Publicado 2019

Emerging Role of Vedolizumab in Managing Refractory Immune Checkpoint Inhibitor–Induced Enteritis

por Diana, Pietro, Mankongpaisarnrung, Charoen, Atkins, Michael B., Zeck, Jay C., Charabaty, Aline
Publicado 2018

Evolving impact of long-term survival results on metastatic melanoma treatment

por Michielin, Olivier, Atkins, Michael B, Koon, Henry B, Dummer, Reinhard, Ascierto, Paolo Antonio
Publicado 2020

Management of metastatic cutaneous melanoma: updates in clinical practice

por Schvartsman, Gustavo, Taranto, Patricia, Glitza, Isabella C., Agarwala, Sanjiv S., Atkins, Michael B., Buzaid, Antonio C.
Publicado 2019

Societal preferences for adjuvant melanoma health states: UK and Australia

por Middleton, Mark R., Atkins, Michael B., Amos, Kaitlan, Wang, Peter Feng, Kotapati, Srividya, Sabater, Javier, Beusterien, Kathleen
Publicado 2017

Strategies for improving the management of immune-related adverse events

por Naing, Aung, Hajjar, Joud, Gulley, James L, Atkins, Michael B, Ciliberto, Gennaro, Meric-Bernstam, Funda, Hwu, Patrick
Publicado 2020

High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014

por Dutcher, Janice P, Schwartzentruber, Douglas J, Kaufman, Howard L, Agarwala, Sanjiv S, Tarhini, Ahmad A, Lowder, James N, Atkins, Michael B
Publicado 2014

LITESPARK-024: A randomized phase 1/2 study of belzutifan with or without palbociclib for previously treated advanced renal cell carcinoma

por McDermott, David F, Peer, Avivit, Agarwal, Neeraj, Atkins, Michael B, Cornell, Jerry, Perini, Rodolfo F, Grossmann, Kenneth F, Gurney, Howard
Publicado 2023

Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy

por Burke, Aidan M., Carrasquilla, Michael, Jean, Walter C., Collins, Brian T., Anaizi, Amjad N., Atkins, Michael B., Gibney, Geoffrey T., Collins, Sean P.
Publicado 2022

Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors

por Mantia, Charlene M., Werner, Lillian, Stwalley, Brian, Ritchings, Corey, Tarhini, Ahmad A., Atkins, Michael B., McDermott, David F., Regan, Meredith M.
Publicado 2021

Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma

por Ribas, Antoni, Kirkwood, John M, Atkins, Michael B, Whiteside, Theresa L, Gooding, William, Kovar, Andreas, Gillies, Stephen D, Kashala, Oscar, Morse, Michael A
Publicado 2009

High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma

por Wang, Xiaoen, Zhang, Liang, Goldberg, S Nahum, Bhasin, Manoj, Brown, Victoria, Alsop, David C, Signoretti, Sabina, Mier, James W, Atkins, Michael B, Bhatt, Rupal S
Publicado 2011